Sun Pharmaceutical Industries Ltd (SUNPHARMA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 948699, "name": "Sun Pharma.Inds.", "stock_name": "Sun Pharma.Inds.", "full_name": "Sun Pharmaceutical Industries Ltd", "name_url": "stocks-analysis/sun-pharmainds", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "1,794.00", "chg": -0.85, "chgp": "-0.05%", "dir": -1, "prev_price": "1,794.85", "mcapval": "433,320.00 Cr", "mcap": "Large Cap", "scripcode": 524715, "symbol": "SUNPHARMA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE044A01036", "curr_date": "Mar 27", "curr_time": "", "bse_nse_vol": "30.51 lacs", "exc_status": "Active", "traded_date": "Mar 27, 2026", "traded_date_str": "2026 03 27", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sun-pharmainds-948699-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Sun Pharmaceutical Industries Ltd is Rated Buy", "link": "https://www.marketsmojo.com/news/stock-recommendation/sun-pharmaceutical-industries-ltd-is-rated-buy-3922751", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_mojoScore_3922751.png", "date": "2026-03-29 10:10:26", "description": "Sun Pharmaceutical Industries Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 23 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 March 2026, providing investors with the latest insights into the company’s performance and outlook." }, { "title": "Sun Pharmaceutical Gains 1.02%: 5 Key Factors Driving the Week’s Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-gains-102-5-key-factors-driving-the-weeks-momentum-3921809", "imagepath": "", "date": "2026-03-28 13:05:12", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>23 Mar:</strong> Stock declined 1.19% amid broad market sell-off</p>\n <p><strong>24 Mar:</strong> Significant open interest surge despite slight price dip</p>\n <p><strong>25 Mar:</strong> Intraday high reached with 3.08% surge and strong derivatives activity</p>\n <p><strong>27 Mar:</strong> Call option activity peaks ahead of expiry; price closes near 52-week high</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.1,777.45</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">..." }, { "title": "Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Market Positioning", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-significant-open-interest-surge-amid-bullish-market-positioning-3920100", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_oi_spurts_by_underlying_3920100.png", "date": "2026-03-27 15:00:53", "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with rising volumes and improved technical indicators, suggests growing investor confidence in the pharmaceutical giant’s near-term prospects." }, { "title": "14,049 Call Contracts Traded on Sun Pharmaceutical Industries Ltd as Stock Nears Rs 1,820 Strike", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-sees-surge-in-call-option-activity-ahead-of-expiry-3919396", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_most_active_stocks_calls_3919396.png", "date": "2026-03-27 12:00:05", "description": "On 27 Mar 2026, 14,049 call contracts at the Rs 1,820 strike price changed hands on Sun Pharmaceutical Industries Ltd, with the stock closing at Rs 1,806. This near at-the-money activity coincides with a two-day rally that has lifted the stock 3.07%, signalling a synchronised directional stance in both the cash and derivatives markets." }, { "title": "P/E at 35.63 vs Industry's 32.13: What the Data Shows for Sun Pharmaceutical Industries Ltd", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-as-a-key-nifty-50-constituent-amid-institutional-confidence-3918629", "imagepath": "", "date": "2026-03-27 09:21:03", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <p><strong>Valuation Picture: Premium Reflecting Sector Confidence</strong></p>\n <p>The current P/E of <a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> stands at 35.63, exceeding the Pharmaceuticals & Biotechnology sector average of 32.13. This premium suggests that investors are willing to pay more for the stock relative to its peers, potentially reflecting expectations of superior earnings growth or stability. However, the premium is moderate rather than extreme, indicating a balanced valuation environment. The market capitalisation of Rs 4,32,600 crores further cements its status as a large-cap stalwart within the sector.</p>\n <p>Such a valuation premium often invites scr..." }, { "title": "Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Momentum", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-significant-open-interest-surge-amid-bullish-momentum-3916520", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_oi_spurts_by_underlying_3916520.png", "date": "2026-03-25 15:00:57", "description": "Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. This development comes alongside a strong price performance, with the stock nearing its 52-week high and outperforming its sector peers, reflecting renewed investor confidence in the large-cap pharmaceutical giant." }, { "title": "Sun Pharmaceutical Industries Ltd Surges 3.08% to Day's High of Rs 1805.9 — Outperforms Sector by 0.63 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-hits-intraday-high-with-strong-308-surge-3916430", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_priceRelatedfactors_3916430.png", "date": "2026-03-25 14:16:30", "description": "The Sensex climbed 1.98% on 25 Mar 2026, yet Sun Pharmaceutical Industries Ltd outpaced the broader market with a 3.08% gain, reaching an intraday high of Rs 1805.9. This 0.63 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector’s 2.49% advance signals a stock-specific strength rather than a mere market tailwind." }, { "title": "Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-sees-significant-open-interest-surge-amid-bullish-market-signals-3916385", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/SunPharmaceutic_oi_spurts_by_underlying_3916385.png", "date": "2026-03-25 14:00:43", "description": "Sun Pharmaceutical Industries Ltd (SUNPHARMA) has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with rising volumes and improved market positioning, suggests a bullish sentiment among traders and investors in the Pharmaceuticals & Biotechnology sector." }, { "title": "P/E at 34.7 vs Industry's 31.5: What the Data Shows for Sun Pharmaceutical Industries Ltd", "link": "https://www.marketsmojo.com/news/stocks-in-action/sun-pharmaceutical-industries-ltd-strengthens-position-amid-nifty-50-dynamics-3915469", "imagepath": "", "date": "2026-03-25 09:21:24", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <p><strong>Valuation Picture: Premium Above Industry Average</strong></p>\n <p><a href=\"https://www.marketsmojo.com/stocks-analysis/sun-pharma.inds.-948699-0\" class=\"stk\">Sun Pharmaceutical Industries Ltd</a> trades at a P/E of 34.71, which is approximately 10% higher than the Pharmaceuticals & Biotechnology industry average of 31.53. This premium suggests that investors are willing to pay more for the stock relative to its peers, potentially reflecting expectations of superior earnings growth or a perception of higher quality within the company’s fundamentals. However, such a premium also raises questions about valuation sustainability, especially in a sector where competitive pressures and regulatory risks are prevalent. The current P/E multiple places the stock in a valu..." } ], "total": 1031, "sid": "948699", "stock_news_url": "https://www.marketsmojo.com/news/sun-pharmaceutical-industries-948699" }, "announcements": [ { "caption": "Updates On Fibromun And Nidlegy", "datetime": "28-Mar-2026", "details": "Updates on Fibromun and Nidlegy", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "27-Mar-2026", "details": "Press Release", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "25-Mar-2026", "details": "Intimation for Trading window closure", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Sun Pharmaceutical Industries Ltd has declared <strong>1100%</strong> dividend, ex-date: 05 Feb 26", "dt": "2026-02-05", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:5</strong> stock split, ex-date: 25 Nov 10", "dt": "2010-11-25", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Sun Pharmaceutical Industries Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 29 Jul 13", "dt": "2013-07-29", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

23 Mar: Stock declined 1.19% amid broad market sell-off

24 Mar: Significant open interest surge despite slight price dip

25 Mar: Intraday high reached with 3.08% surge and strong derivatives activity

27 Mar: Call option activity peaks ahead of expiry; price closes near 52-week high

Week Open

Rs.1,777.45

...

Read full news article

Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Market Positioning

2026-03-27 15:00:53

Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with rising volumes and improved technical indicators, suggests growing investor confidence in the pharmaceutical giant’s near-term prospects.

Read full news article

14,049 Call Contracts Traded on Sun Pharmaceutical Industries Ltd as Stock Nears Rs 1,820 Strike

2026-03-27 12:00:05

On 27 Mar 2026, 14,049 call contracts at the Rs 1,820 strike price changed hands on Sun Pharmaceutical Industries Ltd, with the stock closing at Rs 1,806. This near at-the-money activity coincides with a two-day rally that has lifted the stock 3.07%, signalling a synchronised directional stance in both the cash and derivatives markets.

Read full news article

P/E at 35.63 vs Industry's 32.13: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-03-27 09:21:03

Valuation Picture: Premium Reflecting Sector Confidence

The current P/E of Sun Pharmaceutical Industries Ltd stands at 35.63, exceeding the Pharmaceuticals & Biotechnology sector average of 32.13. This premium suggests that investors are willing to pay more for the stock relative to its peers, potentially reflecting expectations of superior earnings growth or stability. However, the premium is moderate rather than extreme, indicating a balanced valuation environment. The market capitalisation of Rs 4,32,600 crores further cements its status as a large-cap stalwart within the sector.

Such a valuation premium often invites scr...

Read full news article

Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Momentum

2026-03-25 15:00:57

Sun Pharmaceutical Industries Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. This development comes alongside a strong price performance, with the stock nearing its 52-week high and outperforming its sector peers, reflecting renewed investor confidence in the large-cap pharmaceutical giant.

Read full news article

Sun Pharmaceutical Industries Ltd Surges 3.08% to Day's High of Rs 1805.9 — Outperforms Sector by 0.63 Percentage Points

2026-03-25 14:16:30

The Sensex climbed 1.98% on 25 Mar 2026, yet Sun Pharmaceutical Industries Ltd outpaced the broader market with a 3.08% gain, reaching an intraday high of Rs 1805.9. This 0.63 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector’s 2.49% advance signals a stock-specific strength rather than a mere market tailwind.

Read full news article

Sun Pharmaceutical Industries Sees Significant Open Interest Surge Amid Bullish Market Signals

2026-03-25 14:00:43

Sun Pharmaceutical Industries Ltd (SUNPHARMA) has witnessed a notable surge in open interest (OI) in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent price action, combined with rising volumes and improved market positioning, suggests a bullish sentiment among traders and investors in the Pharmaceuticals & Biotechnology sector.

Read full news article

P/E at 34.7 vs Industry's 31.5: What the Data Shows for Sun Pharmaceutical Industries Ltd

2026-03-25 09:21:24

Valuation Picture: Premium Above Industry Average

Sun Pharmaceutical Industries Ltd trades at a P/E of 34.71, which is approximately 10% higher than the Pharmaceuticals & Biotechnology industry average of 31.53. This premium suggests that investors are willing to pay more for the stock relative to its peers, potentially reflecting expectations of superior earnings growth or a perception of higher quality within the company’s fundamentals. However, such a premium also raises questions about valuation sustainability, especially in a sector where competitive pressures and regulatory risks are prevalent. The current P/E multiple places the stock in a valu...

Read full news article

View All News